Business Context and Reporting Period
Company: Grand Canyon Education, Inc. (GCE)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended September 30, 2025
Business Overview: GCE provides technology, academic, counseling, and marketing services to university partners, primarily Grand Canyon University (GCU). As of September 30, 2025, the company serves 20 university partners across the United States. GCU accounted for 89.1% of total service revenue for the nine-month period.
Key Financial Metrics
| Metric (in thousands) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Service Revenue | $261,142 | $238,291 | $797,951 | $740,429 |
| Operating Income | $18,019 | $48,175 | $157,831 | $175,372 |
| Net Income | $16,274 | $41,467 | $129,438 | $144,355 |
| Diluted EPS | $0.58 | $1.42 | $4.60 | $4.91 |
| Operating Cash Flow (9M) | $143,006 (2025) vs $154,141 (2024) | |||
| Cash & Investments | $276,975 (Sep 30, 2025) vs $324,623 (Dec 31, 2024) | |||
| Total Debt | No long-term debt reported; Lease liabilities total $110,528. |
Material Changes vs. Prior Period
- Revenue Growth: Service revenue increased 9.6% in Q3 and 7.8% for the nine months ended September 30, 2025, driven by a 7.9% increase in total partner enrollments to 138,073.
- Profitability Decline: Net income decreased 60.8% in Q3 and 10.3% for the nine months compared to the prior year. This decline is primarily attributed to a $35.0 million reserve for litigation settlement recorded in Q3 2025 related to a False Claims Act (qui tam) lawsuit.
- Expense Increases: Operating expenses rose due to increased headcount, benefit costs, and marketing spend to support enrollment growth. Specific non-recurring charges included $2.4 million for lease termination and impairment.
- Investment Activity: The company shifted from holding no investments at year-end 2024 to holding $179.7 million in available-for-sale securities by September 30, 2025.
Guidance, Outlook, and Risks
- Settlement Status: The $35.0 million litigation settlement is subject to final court review scheduled for mid-November 2025. The company has accrued the full amount in Q3 2025.
- Enrollment Trends: While total enrollments grew, growth in Accelerated Bachelor of Science in Nursing (ABSN) programs is facing headwinds due to a strong job market. The company is adjusting program entry requirements to admit students without completed bachelor's degrees to mitigate this.
- Capital Allocation: The company continues an aggressive share repurchase program. In the first nine months of 2025, it repurchased 874,066 shares for $156.7 million. Approximately $144.4 million remains available under the current authorization expiring March 1, 2026.
- Risk Factors: Key risks include regulatory actions (Title IV compliance), dependence on GCU (89% of revenue), and the outcome of pending class action lawsuits regarding marketing disclosures.
Investor Verification Checklist
- Litigation Settlement: Verify the final court approval of the $35.0 million False Claims Act settlement and confirm no additional penalties are expected.
- Enrollment Quality: Monitor the success of new ABSN program adjustments in stabilizing enrollment growth rates.
- Share Repurchases: Track the pace of remaining share buybacks ($144.4 million authorization) and their impact on diluted share count.
- Legal Exposure: Review updates on pending class actions (Smith and Wang, Ogdon, Valerio) regarding marketing disclosures, as no liability has been accrued for these yet.
- Investment Portfolio: Assess the performance and liquidity of the new $179.7 million investment portfolio in the context of interest rate fluctuations.